Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gourdon

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
The European Journal of Neuroscience|July 29, 2023
The 5-HT<sub>2A/2C</sub> inverse agonist nelotanserin alleviates L-DOPA-induced dyskinesia in the MPTP-lesioned marmosetCynthia Kwan, Imane Frouni, Dominique Bédard, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 9, 2018
Nefazodone reduces dyskinesia, but not psychosis-like behaviours, in the parkinsonian marmosetAdjia Hamadjida, Stephen G Nuara, Dominique Bédard, et al.
European Journal of Pharmacology|December 12, 2022
Anti-parkinsonian effect of the mGlu<sub>2</sub> positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmosetImane Frouni, Cynthia Kwan, Sébastien Belliveau, et al.
Psychopharmacology|July 29, 2023
Effect of the mGlu<sub>4</sub> positive allosteric modulator ADX-88178 on parkinsonism, psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmosetImane Frouni, Cynthia Kwan, Dominique Bédard, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 7, 2018
Development of a selective and sensitive high-performance liquid chromatography-tandem mass spectrometry assay to support pharmacokinetic studies of LY-487,379 in rat and marmosetFleur Gaudette, Adjia Hamadjida, Dominique Bédard, et al.
The European Journal of Neuroscience|June 27, 2024
Effect of the mGlu<sub>2</sub> positive allosteric modulator biphenyl-indanone A as a monotherapy and as adjunct to a low dose of L-DOPA in the MPTP-lesioned marmosetWoojin Kang, Imane Frouni, Cynthia Kwan, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 11, 2024
Positive allosteric mGluR<sub>2</sub> modulation with BINA alleviates dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmosetWoojin Kang, Imane Frouni, Dominique Bédard, et al.
European Journal of Pharmacology|August 2, 2025
Effect of the mGlu<sub>2</sub> receptor positive allosteric modulator AZD8529 on L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmosetJudy Shaqfah, Dominique Bédard, Stephen G Nuara, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 20, 2024
Effect of mGluR<sub>2</sub> and mGluR<sub>2/3</sub> activators on parkinsonism in the MPTP-lesioned non-human primateImane Frouni, Cynthia Kwan, Dominique Bédard, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 4, 2021
Effect of the mGlu<sub>2</sub> positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmosetImane Frouni, Cynthia Kwan, Stephen G Nuara, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
The European Journal of Neuroscience|July 29, 2023
The 5-HT<sub>2A/2C</sub> inverse agonist nelotanserin alleviates L-DOPA-induced dyskinesia in the MPTP-lesioned marmosetCynthia Kwan, Imane Frouni, Dominique Bédard, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 9, 2018
Nefazodone reduces dyskinesia, but not psychosis-like behaviours, in the parkinsonian marmosetAdjia Hamadjida, Stephen G Nuara, Dominique Bédard, et al.
European Journal of Pharmacology|December 12, 2022
Anti-parkinsonian effect of the mGlu<sub>2</sub> positive allosteric modulator LY-487,379 as monotherapy and adjunct to a low L-DOPA dose in the MPTP-lesioned marmosetImane Frouni, Cynthia Kwan, Sébastien Belliveau, et al.
Psychopharmacology|July 29, 2023
Effect of the mGlu<sub>4</sub> positive allosteric modulator ADX-88178 on parkinsonism, psychosis-like behaviours and dyskinesia in the MPTP-lesioned marmosetImane Frouni, Cynthia Kwan, Dominique Bédard, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 7, 2018
Development of a selective and sensitive high-performance liquid chromatography-tandem mass spectrometry assay to support pharmacokinetic studies of LY-487,379 in rat and marmosetFleur Gaudette, Adjia Hamadjida, Dominique Bédard, et al.
The European Journal of Neuroscience|June 27, 2024
Effect of the mGlu<sub>2</sub> positive allosteric modulator biphenyl-indanone A as a monotherapy and as adjunct to a low dose of L-DOPA in the MPTP-lesioned marmosetWoojin Kang, Imane Frouni, Cynthia Kwan, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 11, 2024
Positive allosteric mGluR<sub>2</sub> modulation with BINA alleviates dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmosetWoojin Kang, Imane Frouni, Dominique Bédard, et al.
European Journal of Pharmacology|August 2, 2025
Effect of the mGlu<sub>2</sub> receptor positive allosteric modulator AZD8529 on L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmosetJudy Shaqfah, Dominique Bédard, Stephen G Nuara, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 20, 2024
Effect of mGluR<sub>2</sub> and mGluR<sub>2/3</sub> activators on parkinsonism in the MPTP-lesioned non-human primateImane Frouni, Cynthia Kwan, Dominique Bédard, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 4, 2021
Effect of the mGlu<sub>2</sub> positive allosteric modulator CBiPES on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmosetImane Frouni, Cynthia Kwan, Stephen G Nuara, et al.
Pageof 5